Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Although scientists understand much about diseases like cancer on a molecular level, imaging diseases still relies largely on anatomy–the outline and shape of a tumor or a clot, for instance. Researchers have been working on ways to visualize molecular changes that take place inside the body, and a new method may offer some advantages over existing anatomical and molecular imaging technologies. In a study published online this week in the Proceedings of the National Academies of Sciences, a team of researchers at Stanford University used Raman spectroscopy, a technique common in chemical analysis, paired with specialized nanoparticles to noninvasively visualize organs and tumors in living mice. The technique could be useful for studying complex disease processes in animals, and, if found to be safe in humans, it could help clinicians view multiple molecular changes in certain cancers and other diseases.

Raman spectroscopy detects how objects scatter laser light, a phenomenon named after the Indian physicist Chandrasekhara Venkata Raman, who discovered the effect in the 1920s. Each type of molecule produces a unique Raman signature. There are several techniques that employ the Raman effect, but this study used SERS (surface enhanced Raman scattering), which relies on roughened surfaces of metal nanoparticles to greatly boost the Raman effect. To create Raman nanoparticles, scientists attach small dye molecules, which scatter light, to these molecular amplifiers. They can then affix molecules that allow them to target the particles to a location in the body, such as antibodies that bind to specific proteins in cells.

A study published last December in Nature Biotechnology, led by Shuming Nie at Emory University, used Raman nanoparticles to target and detect tumors in mice. In this study, the Stanford team used two kinds of Raman nanoparticles–a gold sphere and a carbon nanotube–as well as a specialized microscope to create images of the particles in living mice for the first time. The researchers imaged particles accumulating in the liver of the mouse, demonstrating that the technique could visualize structures within the body. They then used a tumor-specific nanoparticle to image tumors in mice.

The key advantage of this technique is that it allows for what imaging researchers call multiplexing: creating images of several different molecules at once. “One of the problems with imaging is, we tend to only be able to look at one or two things at a time,” says Sanjiv Sam Gambhir, lead author of the study and codirector of the Molecular Imaging Program at Stanford. Multiplexing is important in complex diseases like cancer, in which several events occur within tumor cells, each of which could give information about the tumors’ status and the likelihood that it will spread. As a first demonstration of multiplexing, Gambhir’s team injected mice simultaneously with four kinds of Raman nanoparticles at different concentrations and showed that it is possible to locate the different particles and calculate their concentrations based on their Raman signal.

0 comments about this story. Start the discussion »

Credit: Sanjiv Sam Gambhir, Stanford University

Tagged: Biomedicine, disease, nanoparticles, molecular imaging, spectroscopy

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me